Gujarat Alkalies & Chemicals Ltd
Gujarat Alkalies & Chemicals Ltd Q1 FY23 Results & Presentation Highlights: Revenue, Margins & Order Book
Q1 FY23 investor presentation: what the company reported on revenue, margins and projects.
Based on Gujarat Alkalies & Chemicals Ltd's Q1 FY23 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Revenue/Sales for Q1 FY 2022-23: Rs. EBITDA for Q1 FY 2022-23: Rs.
From Gujarat Alkalies & Chemicals Ltd's Q1 FY23 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Revenue/Sales for Q1 FY 2022-23: Rs. 1,106.62 crores (Net External Sales Value, page 9)
- Year-on-year comparison: Q1 FY 2021-22 sales can be approximated as Rs. 920-930 crores (estimated from annual FY 2021-22 Rs. 3,683.40 crores) indicating strong growth in Q1 FY 2022-23. Exact prior quarter figure not explicitly stated.
- Export earnings for Q1 FY 2022-23: Rs. 138 crores (page 13), compared to Rs. 500 crores for full FY 2021-22, showing a partial quarter figure with no explicit YoY % given.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Gujarat Alkalies & Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- CS New plant with Coal based Power plant (JV with NALCO): 800 TPD + 130 MW, Rs. 2300 Cr; CS Plant commissioned and under stabilization; Power Plant one unit commissioned and synchronized.
- Chloromethanes Plant at Dahej: 300 TPD, Rs. 850 Cr; 98.22% progress; commissioning expected August 2022.
- CH-17 Tank Farm: Rs. 80 Cr; 99.67% progress; ready for commissioning.
- Hydrazine Hydrate: 30 TPD, Rs. 405.50 Cr; 93.60% progress; commissioning expected August 2022.
- Caustic Soda expansion at Dahej: 525 TPD, Rs. 550 Cr; 93.20% progress; commissioning expected August 2022.
- Phosphoric acid (new): 100 TPD, Rs. 520 Cr; 84.60% progress; commissioning expected by February 2023.
- Coal-based power plant at Dahej: 65 MW, Rs. 325 Cr; project on hold.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Gujarat Alkalies & Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Gujarat Alkalies & Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.0K Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Gujarat Alkalies & Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- GOCL Corporation Ltd (Q1 FY23)
Q1-FY23 Total Income: INR 4,866 Mn (compared to INR 1,756 Mn in Q1-FY22) — significant increase, exact YoY % not provided but roughly +177%. Key investor presen
- DMCC Speciality Chemicals Ltd (Q1 FY23)
Q1 FY23 Revenue from Operations: ₹113.39 crore, up 60.50% YoY. Key investor presentation takeaways from DMCC Speciality Chemicals Ltd's Q1 FY23 investor present
Frequently Asked Questions
What were Gujarat Alkalies & Chemicals Ltd Q1 FY23 results?
Revenue/Sales for Q1 FY 2022-23: Rs. EBITDA for Q1 FY 2022-23: Rs.
What is Gujarat Alkalies & Chemicals Ltd share price analysis?
Gujarat Alkalies & Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 70.7 with a market cap of ₹4,691 Cr. Investors should review the full earnings analysis for detailed insights.
Is Gujarat Alkalies & Chemicals Ltd planning capital expenditure?
CS New plant with Coal based Power plant (JV with NALCO): 800 TPD + 130 MW, Rs.
Keep Gujarat Alkalies & Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.